Rainer F. Storb

(Reading, Writing, Speaking)

• Sandmaier BM, Fukuda T, Gooley T, Yu C, Santos EB, Storb R, Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model, Experimental Hematology, 31, 168-175, 2003
• Feinstein LC, Sandmaier BM, Hegenbart U, McSweeney PA, Maloney DG, Gooley TA, Maris MB, Chauncey TR, Bruno B, Appelbaum FR, Niederwieser DW, Storb RF, Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission, British Journal of Haematology, 120, 281-288, 2003
• Georges GE, Storb R, Review of 'minitransplantation': nonmyeloablative allogeneic hematopoietic stem cell transplantation, International Journal of Hematology, 77, 3-14, 2003
• Junghanss C, Takatu A, Little M-T, Zaucha JM, Zellmer E, Yunusov M, Sale G, Georges GE, Storb R, Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimeras, Transplantation, 75, 268-274, 2003
• Mielcarek M, Torok-Storb B, Storb R, Is alloantigen expression by host epithelium required for acute graft-versus-host disease? (Letter to the Editor), Nat Med, 9, 150-151, 2003
• Niederwieser D, Maris M, Shizuru JA, Petersdorf E, Hegenbart U, Sandmaier BM, Maloney DG, Storer B, Lange T, Chauncey T, Deininger M, Ponisch W, Anasetti C, Woolfrey A, Little M-T, Blume KG, McSweeney PA, Storb RF, Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclo, Blood, 101, 1620-1629, 2003
• McSweeney PA, Nash RA, Sullivan KM, Storek J, Crofford LJ, Dansey R, Mayes MD, McDonagh KT, Nelson JL, Gooley TA, Holmberg LA, Chen CS, Wener MH, Ryan K, Sunderhaus J, Russell K, Rambharose J, Storb R, Furst DE, High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes, Blood, 100(5), 1602-10, September 2002
• Deeg HJ, Storer B, Slattery JT, Anasetti C, Doney KC, Hansen JA, Kiem HP, Martin PJ, Petersdorf E, Radich JP, Sanders JE, Shulman HM, Warren EH, Witherspoon RP, Bryant EM, Chauncey TR, Getzendaner L, Storb R, Appelbaum FR, Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome, Blood, 100(4), 1201-7, Aug 2002
• Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI, Storb R, Appelbaum FR, Forman SJ, Blume KG, Martin PJ, Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial, Blood, 100(2), 415-9, July 2002
• Koc S, Leisenring W, Flowers ME, Anasetti C, Deeg HJ, Nash RA, Sanders JE, Witherspoon RP, Storb R, Appelbaum FR, Martin PJ, Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone, Blood, 100(1), 48-51, July 2002
• Sandmaier BM, Bethge WA, Wilbur DS, Hamlin DK, Santos EB, Brechbiel MW, Fisher DR, Storb R, Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts, Blood, 100(1), 318-26, July 2002
• Kuhr CS, Allen MD, Junghanss C, Zaucha JM, Marsh CL, Yunusov M, Zellme E, Little MT, Torok-Storb B, Storb R, Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras, Transplantation, 73(9), 1487-92, May 2002
• Carpenter PA, Appelbaum FR, Corey L, Deeg HJ, Doney K, Gooley T, Krueger J, Martin P, Pavlovic S, Sanders J, Slattery J, Levitt D, Storb R, Woolfrey A, Anasetti C, A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease, Blood, 99(8), 2712-9, April 2002
• Junghanss C, Boeckh M, Carter RA, Sandmaier BM, Maris MB, Maloney DG, Chauncey T, McSweeney PA, Little MT, Corey L, Storb R, Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study, Blood, 99(6), 1978-85, March 2002
• Mielcarek M, Zaucha JM, Sandmaier B, Maloney D, Butrynski J, Maris M, Feinstein L, Torok-Storb B, Storb R, Type of post-grafting immunosuppression after non-myeloablative blood cell transplantation may influence risk of delayed haemolysis due to minor ABO incompatibility, British Journal of Haematology, 116(2), 500-1, February 2002
• Furlong T, Leisenring W, Storb R, Anasetti C, Appelbaum FR, Carpenter PA, Deeg HJ, Doney K, Kiem H-P, Nash RA, Sanders JE, Witherspoon R, Thompson D, Martin PJ, Psoralen and ultravioet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease, Biology of Blood and Marrow Transplantation, 8, 206-212, 2002
• Georges GE, Maris M, Sandmaier BM, Maloney DG, Feinstein L, Niederwieser D, Shizuru JA, McSweeney PA, Chauncey TR, Agura E, Little M-T, Sahebi F, Hegenbart U, Pulsipher MA, Bruno B, Forman S, Woolfrey AE, Radich JP, Blume KG, Storb R, Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases, International Journal of Hematology, 76(Suppl. 1), 184-189, 2002
• Georges GE, Storb R, Stem cell transplantation for aplastic anemia, International Journal of Hematology, 75, 141-146, 2002
• Goerner M, Gooley T, Flowers MED, Sullivan KM, Kiem H-P, Sanders JE, Martin PJ, Storb R, Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical sibilngs for patients with aplastic or refractory anemias, Biology of Blood and Marrow Transplantation, 8, 47-56, 2002
• Hogan WJ, Storb R, Clinical developments and reduced intensity haematopoietic stem cell transplantation (Review), Expert Opinion On Biological Therapy, 2, 703-714, 2002
• Junghanss C, Marr KA, Carter RA, Sandmaier BM, Maris MB, Maloney DG, Chauncey T, McSweeney PA, Storb R, Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study, Biology of Blood and Marrow Transplantation, 8, 512-520, 2002
• Junghanss C, Storb R, Boeckh M, Risk of cytomegalovirus infection after transplantation with nonmyeloablative and reduced-intensity conditioning regimens, Blood, 100, 2675-2676, 2002
• Jurado M, Deeg HJ, Storer B, Anasetti C, Anderson JE, Bryant E, Chauncey T, Doney K, Flowers MED, Hansen J, Martin PJ, Nash RA, Petersdorf E, Radich J, Sale G, Sandmaier BM, Storb R, Wade J, Witherspoon R, Appelbaum FR, Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considera, Biology of Blood and Marrow Transplantation, 8, 161-169, 2002
• Kobbe G, Germing U, Aivado M, Zohren F, Schubert D, Strupp C, Pape H, Tenderich G, Korfer R, Storb R, Haas R, Schneider P, Treatment of secondary myelodysplastic syndrome after heart transplantation with chemotherapy and nonmyeloablative stem-cell transplantation, Transplantation, 74, 1198-1200, 2002
• Little M-T, Storb R, History of haematopoietic stem-cell transplantation, Nature Reviews. Cancer, 2, 231-238, 2002
• Mielcarek M, Torok-Storb B, Storb R, ABO incompatibility and relapse risk in patients undergoing allogeneic marrow transplantation for acute myeloid leukemia (Letter to the Editor), Bone Marrow Transplantation, 30, 547-548, 2002
• Nash RA, Takatu A, Feng Z, Slichter S, Abrams K, Espino G, Gass MJ, Georges GE, McSweeney PA, Shulman HM, Storb R, Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: low-dose TBI does not prevent sensitization, Biology of Blood and Marrow Transplantation, 8, 360-367, 2002
• Storb R, Perspective: Haematopoietic stem cell rescue enabling high-dose chemotherapy, tool for immunotherapy, Advances in Transfusion Safety, 108, 123-126, 2002
• Storb R, Mixed allogeneic chimerism and graft-versus-leukemia effects in acute myeloid leukemia (Keynote Address), Leukemia, 16, 753-754, 2002
• Platzbecker U, Gooley T, Anasetti C, Appelbaum FR, Clurman B, Doney K, Chauncey T, Flowers MED, Myerson D, Radich JP, Storb R, Witherspoon RP, Deeg HJ, Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation, Leukemia and Lymphoma, 43, 1409-1414, 2002
• Storb R, Martin PJ, Zaucha JM, Bensinger WI, Flowers MED, Georges G, Gooley T, Chauncey TR, Storek J, Torok-Storb B, Association of CD34 cell number with chronic graft-versus-host disease in adults (Response to Letter to Editor), Blood, 99, 3876-3877, 2002
• Wagner JL, Sarmiento UM, Storb R, Cellular, serological, and molecular polymorphism of the class I and class II loci of the canine major histocompatibility complex, Tissue Antigens, 59, 205-210, 2002
• Warren EH, Tykodi SS, Murata M, Sandmaier BM, Storb R, Jaffee E, Childs R, Thompson JA, Greenberg PD, Riddell SR, T-cell therapy targeting minor histocompatibility Ags for the treatment of leukemia and renal-cell carcinoma, Cytotherapy, 4, 441, 2002
• Woolfrey AE, Pulsipher MA, Storb R, Non-myeloablative hematopoietic cell transplant for treatment of nonmalignant disorders in children, In J Hematol, 76(Suppl. II), 271-277, 2002
• Xun CQ, Little MT, Zellmer E, Yu C, Zaucha JM, Sale GE, Storer B, Storb R, What role for FTY720, a novel immunosuppressive agent, in canine nonmyeloablative hematopoietic stem cell transplantation?, Transplantation, 73(2), 310-3, January 2002
• Yunusov MY, Kuhr C, Georges GE, Sale GE, Spector M, Lesnikova M, Lee R, Little M-T, Gass MJ, Weber K, Joslyn A, Storb R, Nash RA, Survival of small bowel transplants in canine mixed hematopoietic chimeras: preliminary results, Transplant Proc, 34, 3366-3367, 2002
• Zaucha JM, Mielcarek M, Takatu A, Little M-T, Gooley T, Baker J, Maloney DG, Sandmaier BM, Maris M, Chauncey T, Storb R, Torok-Storb B, Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation, British Journal of Haematology, 119, 740-750, 2002
• Benito AI, Furlong T, Martin PJ, Anasetti C, Appelbaum FR, Doney K, Nash RA, Papayannopoulou T, Storb R, Sullivan KM, Witherspoon R, Deeg HJ, Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease, Transplantation, 72(12), 1924-9, December 2001
• Georges GE, Storb R, Bruno B, Brodie SJ, Thompson JD, Taranova AG, Zaucha JM, Little MT, Zellmer E, Moore PF, Gooley T, Sale G, Kiem HP, Sandmaier BM, Lyons RM, Nash RA, Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes, Blood, 98(12), 3447-55, December 2001
• Kansu E, Gooley T, Flowers ME, Anasetti C, Deeg HJ, Nash RA, Sanders JE, Witherspoon RP, Appelbaum FR, Storb R, Martin PJ, Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial, Blood, 98(13), 3868-70, December 2001
• Storek J, Joseph A, Espino G, Dawson MA, Douek DC, Sullivan KM, Flowers ME, Martin P, Mathioudakis G, Nash RA, Storb R, Appelbaum FR, Maloney DG, Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation, Blood, 98(13), 3505-12, December 2001
• Weissinger F, Sandmaier BM, Maloney DG, Bensinger WI, Gooley T, Storb R, Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings, Blood, 98(13), 3584-8, December 2001
• Zaucha JM, Gooley T, Bensinger WI, Heimfeld S, Chauncey TR, Zaucha R, Martin PJ, Flowers ME, Storek J, Georges G, Storb R, Torok-Storb B, CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics, Blood, 98(12), 3221-7, December 2001
• Goerner M, Horn PA, Peterson L, Kurre P, Storb R, Rasko JE, Kiem HP, Sustained multilineage gene persistence and expression in dogs transplanted with CD34(+) marrow cells transduced by RD114-pseudotype oncoretrovirus vectors, Blood, 98(7), 2065-70, October 2001
• Torok-Storb B, Bolles L, Iwata M, Doney K, Sale GE, Gooley TA, Storb R, Increased prevalence of CMV gB3 in marrow of patients with aplastic anemia, Blood, 98(3), 891-2, August 2001
• Ulrich CM, Yasui Y, Storb R, Schubert MM, Wagner JL, Bigler J, Ariail KS, Keener CL, Li S, Liu H, Farin FM, Potter JD, Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism, Blood, 98(1), 231-4, July 2001
• Storb R, Sale G, Transient mixed hematopoietic chimerism in dogs given thymic irradiation before and pharmacologic immunosuppression after marrow transplantation, Blood, 97(9), 2915-2916, May 2001
• Zaucha JM, Zellmer E, Georges G, Little MT, Storb R, Storer B, Torok-Storb B, G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 7(11), 613-9, 2001
• Maris M, Woolfrey A, McSweeney PA, Sandmaier BM, Nash RA, Georges G, Maloney DG, Molina A, Chauncey T, Yu C, Zaucha JM, Blume KG, Shizuru J, Niederwieser D, Storb R, Nonmyeloablative hematopoietic stem cell transplantation: transplantation for the 21st century, Frontiers in Bioscience, 6, g13-16, 2001
• Maris M, Sandmaier BM, Maloney DG, McSweeney PA, Woolfrey A, Chauncey T, Shizuru J, Niederwieser D, Blume KG, Forman S, Storb R, Non-myeloablative hematopoietic stem cell transplantation, Transfusion Clinique et Biologique, 8, 231-234, 2001
• Storb R, Nonmyeloablative preparative regimens: how relevant for acute myelogenous leukemia? (Editorial), Leukemia, 15, 662-663, 2001
• Walters MC, Patience M, Leisenring W, Rogers ZR, Aquino VM, Buchanan GR, Roberts IAG, Yeager AM, Hsu L, Adamkiewicz T, Kurtzberg J, Vichinsky E, Storer B, Storb R, Sullivan KM, Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia, Biology of Blood and Marrow Transplantation, 7, 665-673, 2001
• Witherspoon RP, Deeg HJ, Storer B, Anasetti C, Storb R, Appelbaum FR, Hematopoietic stem-cell transplnatation for treatment-related leukemia or myelodysplasia, Journal of Clinical Oncology, 19, 2134-2141, 2001
• Woolfrey A, Pulsipher MA, Storb R, Nonmyeloablative hematopoietic cell transplant for treatment of immunde deficiency, Current Opinion in Pediatrics, 13, 539-545, 2001
• Feinstein L, Storb R, Nonmyeloablative hematopoietic cell transplantation, Curr. Opin. Oncol, 13, 95-100, 2001
• Anderson JE, Appelbaum FR, Schoch G, Barnett T, Chauncey TR, Flowers MED, Storb R, Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation, Biology of Blood and Marrow Transplantation, 7, 163-170, 2001
• Al-Ghamdi H, Leisenring W, Bensinger WI, Nash RA, Storb R, Appelbaum FR, Martin PJ, A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interest, British Journal of Haematology, 113, 461-469, 2001
• McSweeney PA, Niederwieser D, Shizuru J, Molina AJ, et al., Hematopoietic cell transplantation in older patients with hematologic malignancies replacing high-dose cytotoxic therapy with graft-versus-tumor effects, Blood, 97, 3390-3400, 2001
• Witherspoon RP, Deeg HJ, Storb R, Appelbaum FR, Secondary leukemia or myelodysplasia treated by bone marrow transplantation, Proceedings of Acute Leukemias VIII: Prognostic Factors and Treatment Strategies, 655-659, 2001
• Storb R, McSweeney PA, Sandmaier BM, Nash RA, Georges G, Maloney DG, Molina A, Maris M, Woolfrey A, Chauncey T, Zaucha JM, Blume KG, Shizuru J, Niederwieser D, Nonmyeloablative allografts: from the laboratory to the clinic, Autologous Blood and Marrow Transplantation: Proceedings of the Tenth International Symposium, Dallas, TX, Chapter 7, 315-320, 2001
• Zaucha JM, Yu C, Lothrop CD Jr, Nash RA, Sale G, Georges G, Kiem H-P, Niemeyer GP, Dufresne M, Cao Q, Storb R, Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantation, Biology of Blood and Marrow Transplantation, 7, 14-24, 2001
• Storb R, Blume KG, O'Donnell MR, Chauncey T, Forman SJ, Deeg Hj, Hu WW, Appelbaum FR, Doney K, Flowers MED, Sanders J, Leisenrng W, Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers, Biology of Blood and Marrow Transplantation, 7, 39-44, 2001
• Bruno B, Gooley T, Sullivan KM, Davis C, Bensinger WI, Storb R, Nash RA, Secondary failure of platelet recovery after hematopoietic stem cell transplantation, Biology of Blood and Marrow Transplantation, 7, 154-162, 2001
• Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA, Witherspoon RP, Bensinger W, Flowers MED, Martin P, Storb R, Appelbaum FR, Boeckh M, Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation, Blood, 97(11), 3380-3389, 2001
• Zaucha JM, Yu C, Mathioudakis G, Seidel K, Georges G, Sale G, Little M-T, Torok-Storb B, Storb R, Hematopoietic responses to stress conditions in young dogs compared with elderly dogs, Blood, 98(2), 322-327, 2001
• Al-Ghamdi H, Leisenring W, Bensinger WI, Nash RA, Storb R, Appelbaum FR, Martin PJ, A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interest, British Journal of Haematology, 113, 461-469, 2001
• Ulrich CM, Yasui Y, Storb R, Schubert MM, Wagner JL, Bigler J, Ariail KS, Keener CL, Li S, Liu H, Farin FM, Potter JD, Pharmacogenetics of methotrexate: Toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism, Blood, 98(1), 231-234, 2001
• Wagner JL, Flowers MED, Longton G, Storb R, Martin P, Use of screening studies to predict survival among patients who do not have chronic graft-versus-host disease at day 100 after bone marrow transplantation, Biology of Blood and Marrow Transplantation, 7, 239-240, 2001
• Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R, Kashyap A, Flowers MED, Lilleby K, Chauncey TR, Storb R, Appelbaum FR, Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers, New England Journal of Medicine, 344, 175-181, 2001
• Jurado M, Deeg HJ, Gooley T, Anasetti C, Chauncey T, Flowers MED, Myerson D, Storb R, Appelbaum FR, Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia, British Journal of Haematology, 112, 392-396, 2001
• Bensinger WI, Maloney D, Sandmaier BM, Molina A, Sahebi F, Forman SJ, Storb R, Non-ablative allogeneic transplants for multiple myeloma, VIII International Myeloma Workshop, Banff, Alberta, Canada, May 4-8, 36-37, 2001
• Bensinger WI, Maloney D, Storb R, Allogeneic hematopoietic cell transplantation for multiple myeloma, Seminars in Hematology, 38, 243-249, 2001
• Bensinger WI, Storb R, Allogeneic peripheral blood stem cell transplantation, Hopkins HIV Rep, 5, 67-86, 2001
• Bruno B, Goerner M, Nash RA, Storb R, Kiem H-P, Purified canine CD34+Lin- marrow cells transduced with retroviral vectors give rise to long-term multi-lineage hematopoiesis, Biology of Blood and Marrow Transplantation, 7, 543-551, 2001
• Bruno B, Goerner M, Nash RA, Storb R, Kiem H-P, Purified canine CD34+Lin- marrow cells transduced with retroviral vectors give rise to long-term multi-lineage hematopoiesis, Biology of Blood and Marrow Transplantation, 7, 543-551, 2001
• Feinstein L, Sandmaier B, Maloney D, McSweeney PA, Maris M, Flowers C, Radich J, Little M-T, Nash RA, Chauncey T, Woolfrey A, Georges G, Kiem H-P, Zaucha JM, Blume KG, Shizuru J, Niederwieser D, Storb R, Nonmyeloablative hematopoietic cell transplantaiton: replacing high-dose cytotoxic therapy by the graft-versus-tumor effect, Annals of the New York Academy of Sciences, 938, 328-339, 2001
• Feinstein L, Sandmaier B, Maloney D, McSweeney PA, Maris M, Flowers C, Radich J, Little M-T, Nash RA, Chauncey T, Woolfrey A, Georges G, Kiem H-P, Zaucha JM, Blume KG, Shizuru J, Niederwieser D, Storb R, Nonmyeloablative hematopoietic cell transplantaiton: replacing high-dose cytotoxic therapy by the graft-versus-tumor effect, Annals of the New York Academy of Sciences, 938, 328-339, 2001
• Little MT, Storb R, The future of allogeneic hematopoietic stem cell transplantation: minimizing pain, maximizing gain [comment], Journal of Clinical Investigation, 105(12), 1679-81, June 2000
• Georges GE, Storb R, Thompson JD, Yu C, Gooley T, Bruno B, Nash RA, Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation, Blood, 95(10), 3262-9, May 2000
• Deeg HJ, Shulman HM, Anderson JE, Bryant EM, Gooley TA, Slattery JT, Anasetti C, Fefer A, Storb R, Appelbaum FR, Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age, Blood, 95(4), 1188-94, February 2000
• Yu C, Linsley P, Seidel K, Sale G, Deeg HJ, Nash RA, Storb R, Cytotoxic T lymphocyte antigen 4-immunoglobulin fusion protein combined with methotrexate/cyclosporine as graft-versus-host disease prevention in a canine dog leukocyte antigen-nonidentical marrow tra, Transplantation, 69(3), 450-4, February 2000
• Zang DY, Deeg HJ, Gooley T, Anderson JE, Anasetti C, Sanders J, Myerson D, Storb R, Appelbaum F, Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation, British Journal of Haematology, 110, 217-222, 2000
• Walters MC, Storb R, Patience M, Leisenring W, et al., Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report, Blood, 95, 1918-1924, 2000
• Georges G, Storb R., HLA-identical sibling hematopoietic stem cell transplantation for severe aplastic anemia, Clinical Bone Marrow and Blood Stem Cell Transplantation, 2nd Edition, Chapter 40, 515-527, 2000
• Kiem H-P, Storb R., Canine models for transplantation and gene therapy, Hematopoietic Stem Cell Transplantation, Chapter 11, 171-194, 2000
• Georges G, Storb R., Failure of sustained engraftment: clinical manifestations and treatment, Clinical Bone Marrow and Blood Stem Cell Transplantation, 2nd Edition, Chapter 52, 662-680, 2000
• Storb R, Yu C, McSweeney P, Nash R, Sandmaier B, Wagner J, Woolfrey A, New strategies for hematopoietic stem cell transplantation, Transplantation in Hematology and Oncology, 97-111, 2000
• McCann SR, Passweg JR, Storb R, Deeg HJ, HLA-identical sibling bone marrow transplantation to treat severe aplastic anemia, Aplastic Anemia Pathophysiology and Treatment, Chapter 12, 230-257, 2000
• Witherspoon RP, Deeg HJ, Fisher L, Schoch G, Storb R, Secondary malignancies after allogeneic or autologous marrow transplantation, Secondary Neoplasias following Chemotherapy, Radiotherapy, and Immunosuppression, 55, 203-224, 2000
• Molina AJ, Sandmaier BM, Storb R, Nonmyeloablative hematopoietic stem cell allografting, Current Opinion in Organ Transplantation, 5, 366-371, 2000
• Sandmaier BM, McSweeney P, Yu C, Storb R, Non-myeloablative transplants: preclinical and clinical results, Seminars in Oncology, 27(Suppl. 5), 78-81, 2000
• Storb R, McSweeney PA, Sandmaier BM, Nash RA, Georges G, Maloney D, Yu C, Zaucha M, Blume K, Shizuru J, Niederwieser D, Non-myeloablative haematopoietic stem cell transplants, Proceedings of the 4th Stem Cell Workshop: High-dose Therapy and Transplantation of Haematopoietic Stem Cells, Chapter 5.2, 170-174, 2000
• Cavallaro AM, Lilleby K, Majolino I, Storb R, Appelbaum FR, Rowley SD, Bensinger WI, Three to six year follow-up of normal donors who received recombinant human granulocyte colony stimulating factor, Bone Marrow Transplantation, 25, 85-89, 2000
• Bhattacharya V, McSweeney PA, Shi Q, Bruno B, Ishida A, Nash R, Storb RF, Sauvage LR, Hammond WP, Wu MH-D, Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34+ bone marrow cells, Blood, 95, 581-585, 2000
• Carella AM, Champlin R, Slavin S, McSweeney P, Storb R, Mini-allografts: ongoing trials in humans (Editorial), Bome Marrow Transplant, 25, 345-350, 2000
• Storb R, McSweeney PA, Sandmaier BM, Nash RA, Georges G, Maloney DG, Molina A, Chauncey T, Yu C, Zaucha JM, Blume KG, Shizuru J, Niederwieser D, Allogeneic hematopoietic stem cell transplantation: from the nuclear age into the 21st century, Transplantation Proceedings, 32, 2548-2549, 2000
• Molina AJ, Storb RF, Hematopoietic stem cell transplantation in older adults, Handbook of Bone Marrow Transplantation, 1st Edition, Chapter 6, 111-137, 2000
• Storek J, Storb R, T-cell reconstitution after stem-cell transplantation- by which organ? (Commentary), Lancet, 355, 1843-1844, 2000
• Mielcarek M, Leisenring W, Torok-Storb B, Storb R, Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect, Blood, 96, 1150-1156, 2000
• Wagner JL, Creer SA, Storb R, Dog class I gene DLA-88 histocompatibility typing by PCR-SSCP and sequencing (Brief Communication), Tissue Antigens, 55, 564-567, 2000
• Deeg HJ, Flowers MED, Leisenring W, Appelbaum FR, Martin PJ, Storb RF, Cyclosporine (CSP) or CSP plus methylprednisolone for graft-versus-host disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial (Letter, Blood, 96, 1194-1195, 2000
• Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AM, Prezepiorka D, Davies S, Petersen FB, Bartels P, Buell D, Fitzsimmons W, Anasetti C, Storb R, Ratanatharathorn V, Phase 3 Study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors, Blood, 96, 2062-2068, 2000
• Hagglund HG, McSweeney PA, Mathioudakis G, Bruno B, Georges GE, Gass MJ, Moore P, Sale GE, Storb R, Nash RA, Ex vivo expansion of canine dendritic cells from CD34+ bone marrow progenitor cells, Transplantation, 70, 1437-1442, 2000
• Wagner JL, Storb R, Storer B, Mignot E, DLA-DQB1 alleles and bone marrow transplantation experiments in narcoleptic dogs, Tissue Antigens, 56, 223-231, 2000
• Flowers MED, Leisenring W, Beach K, Riddell S, Radich JP, Higano C, Rowley SD, Chauncey TR, Bensinger WI, Sanders JE, Anasetti C, Storb R, Wade J, Appelbaum FR, Martin PJ, Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marr, Biology of Blood and Marrow Transplantation, 6, 321-326, 2000
• Sandmaier BM, McSweeney PA, Niederwieser D, Maloney DG, Blume KG, Molina A, Shizuru J, Chauncey T, Georges G, Zaucha JM, Maris M, Woolfrey A, Storb R, Post-transplant immunosuppression- canine models and clinical application, New Frontiers in Cancer Therapy: Non-myeloablative Stem Cell Transplantation (NST), 1st Edition, 37-43, 2000
• Sierra J, Storer B, Hansen JA, Martin PJ, Petersdorf EW, Woolfrey A, Matthews D, Sanders JE, Storb R, Appelbaum FR, Anasetti C, Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience, Bone Marrow Transplantation, 26, 397-404, 2000
• Carnevale-Schianca F, Martin P, Sullivan K, Flowers M, Gooley T, Anasetti C, Deeg J, Furlong T, McSweeney P, Storb R, Nash RA, Changing cyclosporine to tacrolimus as salvage therapy for chronic graft-versus-host disease, Biology of Blood and Marrow Transplantation, 6, 613-620, 2000
• Furlong T, Storb R, Anasetti C, Appelbaum FR, Deeg HJ, Doney K, Martin P, Sullivan K, Witherspoon R, Nash RA, Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities, Bone Marrow Transplantation, 26, 985-991, 2000
• Mathioudakis G, Storb R, McSweeney PA, Torok-Storb B, Lansdorp PM, Brummendorf TH, Gass MJ, Bryant EM, Storek J, Flowers MED, Gooley T, Nash RA, Polyclonal hematopoiesis with variable telomere shortening in human long-term allogeneic marrow graft recipients (Brief Report), Blood, 96, 3991-3994, 2000
• Mosca JD, Hendricks JK, Buyaner D, Davis-Sproul J, Chuang L-C, Majumdar MK, Chopra R, Barry F, Murphy M, Thiede MA, Junker U, Rigg RJ, Forestell SP, Bohnlein E, Storb R, Sandmaier BM, Mesenchymal stem cells as vehicles for gene delivery, Clinical Orthopaedics and Related Research (Orthopaedic Gene Therapy Supplement), 379S, S71-S90, 2000
• Koc S, Leisenring W, Flowers MED, Anasetti C, Deeg HJ, Nash RA, Sanders JE, Witherspoon RP, Appelbaum FR, Storb R, Martin PJ, Thalidomide for treatment of patients with chronic graft-versus-host disease, Blood, 96, 3995-3996, 2000
• Niederwieser D, McSweeney P, Hegenbart U, Ponisch W, Lange T, Deininger M, Uharek L, Storb R, Haematopoietic stem cell transplantation with reduced conditioning: a new treatment modality for patients at high risk of transplant-related mortality, European Haematology Association Educational Book, Fifth Congress of the European Haematology Association Birmingham, UK, 25-28 June 2000, 59-60, 2000
• Storb R, Allogeneic hematopoietic stem cell transplantation from the nuclear age to the 21st century: lessons learned from dogs, Proceedings of the 18th Annual Veterinary Medical Forum, Lakewood, CO: American College of Veterinary Internal Medicine, Session #191, 479-480, 2000
• Storb R, McSweeney PA, Sandmaier BM, Nash RA, Georges G, Maloney DG, Molina A, Maris M, Woolfrey A, Chauncey T, Zaucha M, Blume KG, Shizuru J, Niederwieser D, Nonmyeloablative allogeneic hematopoietic stem cell transplantation, Hematologica, 85 Suppl.2, 85-87, 2000
• Wagner JL, Seidel K, Boeckh M, Storb R, De novo chronic graft-versus-host disease in marrow graft recipients given methotrexate and cyclosporine: risk factors and survival, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, 6(6), 633-9, 2000
• Xun CQ, McSweeney PA, Boeckh M, Storb RF, Broudy VC, Thompson JA, Successful nonmyeloablative allogeneic hematopoietic stem cell transplant in an acute leukemia patient with chemotherapy-induced marrow aplasia and progressive pulmonary aspergillosis [letter], Blood, 94(9), 3273-6, November 1999
• Storb R, Yu C, Zaucha JM, Deeg HJ, Georges G, Kiem HP, Nash RA, McSweeney PA, Wagner JL, Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant, Blood, 94(7), 2523-9, October 1999
• Storb R, Yu C, Barnett T, Wagner JL, Deeg HJ, Nash RA, Kiem HP, McSweeney P, Seidel K, Georges G, Zaucha JM, Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation., Blood, 94(3), 1131-6, 1 Aug 1999
• Shi Q, Wu H-D, Fujita Y, Ishida A, Wijelath ES, Hammond WP, Wechezak AR, Yu C, Storb RF, Sauvage LR, Genetic tracing of arterial graft flow surface endothelialization in allogeneic marrow transplanted dogs, Cardiovascular Surgery, 7, 98-104, 1999
• Mielcarek M, Bryant E, Loken M, Torok-Storb B, Storb R, Haemopoietic reconstitution by donor-derived myelodysplastic progenitor cells after haemopoietic stem cell transplantation (Report), British Journal of Haematology, 105, 361-365, 1999
• Storb R, Raff RF, Graham T, Appelbaum FR, Deeg HJ, Schuening FG, Sale G, Seidel K, Dose rate-dependent marrow toxicity of TBI in dogs and marrow sparing effect at high dose rate by dose fractionation., Biology of Blood and Marrow Transplantation, 5(3), 155-61, 1999
• McSweeney PA, Storb R, Mixed chimerism: preclinical studies and clinical applications, Biology of Blood and Marrow Transplantation, 5(4), 192-203, 1999
• Wagner JL, Burnett RC, Storb R, Organization of the canine major histocompatibility complex: current perspectives, Journal of Heredity, 90(1), 35-8, 1999
• Storb R, Yu C, McSweeney P., Mixed Chimerism After Transplantation of Allogeneic Hematopoietic Cells, In Hematopoietic Cell Transplantation, 2nd Edition, Thomas ED,(eds)et al(Boston: Blackwell Sc), 287-295, 1999
• Thomas ED, Storb R., The Development of the Scientific Foundation of Hematopoietic Cell Transplantation Based on Animal and Human Studies, In: Hematopoietic Cell Transplantation, 2nd edition, Thomas Ed,(eds)et al(Boston: Blackwell Sc), 1-11, 1999
• Matthews DC, Appelbaum FR, Eary JF, Fisher DR, Durack LD, et al., Phase I Study of 131 I-Anti-CD45 Antibody Plus cyclophosphamide and Total Body Irradiation For Advanced Acute Leukemia and Myelodysplastic Syndrome, Blood, 94, 1237-1247, 1999
• Wagner JL, Storb R, Allogeneic transplantation for aplastic anemia, Hematopoietic Cell Transplantation, 2nd Edition, Chapter 67, 791-806, 1999
• Storb R, Yu C, Sandmaier BM, McSweeney PA, Georges G, Nash RA, Woolfrey A, Mixed hematopoietic chimerism after marrow allografts: transplantation in the ambulatory care setting, Hematopoietic Stem Cells Biology and Transplantation, 872, 372-376, 1999
• Sandmaier BM, Yu C, Barsoukov A, Storb R, Canine hematopoietic stem cell allografts using nonmyeloablative therapy, Autologous Blood and Marrow Transplantation, Proceedings of the Ninth International Symposium, Arlington, Texas, 601-611, 1999
• Storb R, Yu C, Sandmaier B, McSweeney P, Georges G, Nash R, Woolfrey A, Mixed hematopoietic chimerism after hematopoietic stem cell allografts, Transplant Proc, 31, 677-678, 1999
• Barsoukov AA, Moore PF, Storb R, Santos EB, Sandmaier BM, The use of an anti-TCR alpha beta monoclonal antibody to control host-versus-graft reactoins in canine marrow allograft recipients conditioned with low dose total body irradiation, Transplantation, 67, 1329-1335, 1999
• Storb R, Nonmyeloablative preparative regimens: experimental data and clinical practice, ASCO Education Book, 241-249, 1999
• Bruno B, Nash RA, Wallace PM, Gass MJ, Thompson J, Storb R, McSweeney PA, CD34+ selected boen marrow grafts are radioprotective and establish mixed chimerism in dogs given high dose total body irradiation, Transplantation, 68, 338-344, 1999
• Kiem H-P, McSweeney PA, Bruno B, Goerner M, Buron G, Morris J, Storb R, Miller AD, Improved gene transfer into canine hematopoietic repopulating cells using CD34-enriched marrow cells in combination with a gibbon ape leukemia virus-pseudotype retroviral vector, Gene Therapy, 6, 966-972, 1999
• Yamaguchi M, McSweeney PA, Kimball L, Gersuk G, Hong DS, Kwok W, Storb R, Beckham C, Deeg HJ, Recognition of major histocompatibility complex class II antigens by two anti-HLA-DR monoclonal antibodies on canine marrow cells correlates with effects on in vitro and in vivo hematopoiesis, Transplantation, 68, 1161-1171, 1999
• Deeg HJ, Schuler US, Shulman H, Ehrsam M, Renner U, Yu C, Storb R, Ehninger G, Myeloablation by intravenous busulfan and hematopoietic reconstitution with autologus marrow in a canine model, Biology of Blood and Marrow Transplantation, 5, 316-321, 1999
• Storb R, Prevention of graft-versus-host disease, Turkish Journal of Haematology, 16, 107-111, 1999
• Storb R, McSweeney PA, Sandmaier BM, Nash RA, Georges G, Maloney DG, Molina A, Chauncey T, Yu C, Zaucha M, Nonmyeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation, Turkish Journal of Haematology, Supplement to Volume 16, No. 3, 3rd National Bone Marrow and Peripheral Stem Cell Transplantation Congress, 3-5 June, Mersin, Turkey, 3-7, 1999
• Goerner M, Bruno B, McSweeney PA, Buron G, Storb R, Kiem H-P, The use of granulocyte colony-stimulating factor during retroviral transduction on fibronectin fragment CH-296 enhances gene transfer into hematopoietic repopulating cells in dogs, Blood, 94, 2287-2292, 1999
• Martin PJ, Rowley SD, Anasetti C, Chauncey TR, Gooley T, Petersdorf EW, van Burik J-A, Flowers MED, Storb R, Appelbaum FR, Hansen JA, A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients, Blood, 94, 2192-2199, 1999
• McSweeney P, Storb R, Establishing mixed chimerism with immunosuppressive, minimally myelosuppressive conditioning: preclinical and clinical studies, Hematology 1999, The American Society of Hematology Education Program Book, 396-405, 1999
• Clift RA, Radich J, Appelbaum FR, Martin P, Flowers MED, Deeg HJ, Storb R, Thomas ED, Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogeneic marrow transplants during chronic p, Blood, 94, 3960-3962, 1999
• Feinstein LC, Seidel K, Jocum J, Bowden RA, Anasetti C, Deeg HJ, Flowers MED, Kansu E, Martin PJ, Nash RA, Storek J, Etzioni R, Appelbaum FR, Hansen JA, Storb R, Sullivan KM, Reduced dose intravenous immunoglobulin does not decrease transpalnt-related complications in adults given related donor marrow allografts, Biology of Blood and Marrow Transplantation, 5, 369-378, 1999
• Ratanatharathorn V, Nash R A, Przepiorka D, Devine S M, Klein J L, Weisdorf D, Fay J W, Nademanee A, Antin J H, Christiansen N P, van der Jagt R, Herzig R H, Litzow M R, Wolff S N, Longo W L, Petersen F B, Karanes C, Avalos B, Storb R, Buell D N, Maher R M, Fitzsimmons W E, Wi, Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantat, Blood, 92(7), 2303-14, 1 Oct 1998
• Georges G E, Storb R, Brunvand M W, Kiem H P, Moore P F, Malik P, Ennist D, Nash R A, Canine T cells transduced with a herpes simplex virus thymidine kinase gene: a model to study effects on engraftment and control of graft-versus-host disease., Transplantation, 66(4), 540-4, 27 Aug 1998
• Clift R A, Buckner C D, Appelbaum F R, Sullivan K M, Storb R, Thomas E D, Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia, Blood, 92(4), 1455-6, 15 Aug 1998
• Morton A J, Gooley T, Hansen J A, Appelbaum F R, Bruemmer B, Bjerke J W, Clift R, Martin P J, Petersdorf E W, Sanders J E, Storb R, Sullivan K M, Woolfrey A, Anasetti C, Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase., Blood, 92(2), 394-401, 15 Jul 1998
• Shi Q, Rafii S, Wu M H, Wijelath E S, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage L R, Moore M A, Storb R F, Hammond W P, Evidence for circulating bone marrow-derived endothelial cells., Blood, 92(2), 362-7, 15 Jul 1998
• Sullivan K M, Anasetti C, Horowitz M, Rowlings P A, Petersdorf E W, Martin P J, Clift R A, Walters M C, Gooley T, Sierra J, Anderson J E, Bjerke J, Siadak M, Flowers M E, Nash R A, Sanders J E, Appelbaum F R, Storb R, Hansen J A, Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant, Annals of The New York Academy of Sciences, 850, 312-24, 30 Jun 1998
• Storb R, Yu C, Deeg H J, Georges G, Kiem H P, Mcsweeney P A, Nash R A, Sandmaier B M, Sullivan K M, Wagner J L, Walters M C, Current and future preparative regimens for bone marrow transplantation in thalassemia., Annals of The New York Academy of Sciences, 850, 276-87, 30 Jun 1998
• Deeg H J, Leisenring W, Storb R, Nims J, Flowers M E, Witherspoon R P, Sanders J, Sullivan K M, Long-term outcome after marrow transplantation for severe aplastic anemia., Blood, 91(10), 3637-45, 15 May 1998
• Sandmaier B M, Storb R, Bennett K L, Appelbaum F R, Santos E B, Epitope specificity of CD44 for monoclonal antibody-dependent facilitation of marrow engraftment in a canine model., Blood, 91(9), 3494-502, 1 May 1998
• Hansen JA, Gooley TA, Martin PJ, Appelbaum F, Chauncey TR, Clift RA, Petersdorf EW, Radich J, Sanders JE, Storb RF, Sullivan KM, Anasetti C, Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia [see comments, New England Journal of Medicine, 338(14), 962-8, 2 1998
• Hansen J A, Gooley T A, Martin P J, Appelbaum F, Chauncey T R, Clift R A, Petersdorf E W, Radich J, Sanders J E, Storb R F, Sullivan K M, Anasetti C, Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia, New England Journal of Medicine, 338(14), 962-8, 2 Apr 1998
• Graumann M B, DeRose S A, Ostrander E A, Storb R, Polymorphism analysis of four canine MHC class I genes., Tissue Antigens, 51(4 Pt 1), 374-81, April 1998
• Yu C, Seidel K, Nash R A, Deeg H J, Sandmaier B M, Barsoukov A, Santos E, Storb R, Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts., Blood, 91(7), 2581-7, 1 Apr 1998
• McSweeney P A, Rouleau K A, Wallace P M, Bruno B, Andrews R G, Krizanac-Bengez L, Sandmaier B M, Storb R, Wayner E, Nash R A, Characterization of monoclonal antibodies that recognize canine CD34., Blood, 91(6), 1977-86, 15 Mar 1998
• Storb R, Raff R, Deeg H J, Graham T, Appelbaum F R, Schuening F G, Shulman H, Seidel K, Leisenring W, Dose rate-dependent sparing of the gastrointestinal tract by fractionated total body irradiation in dogs given marrow autografts., International Journal of Radiation Oncology, Biology, Physics, 40(4), 961-6, 1 Mar 1998
• Martin P, Nash R, Sanders J, Leisenring W, Anasetti C, Deeg H J, Storb R, Appelbaum F, Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation., Bone Marrow Transplantation, 21(3), 273-9, February 1998
• Anderson JE, Sale G, Appelbaum FR, Chauncey TR, Storb R., Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis, British Journal of Haematology, 98, 1010-1016, 1998
• McSweeney PA, Storb R., Hematopoietic stem cell transplantation, Encyclopedia of Immunology, Second Edition, 1062-1070, 1998
• Georges GE, Sandmaier BM, Storb R., Animal Models, Blood Stem Cell Transplantation., 1-17, 1998
• McSweeney PA, Storb R., Marrow and peripheral blood stem cell transplantation, Advances in Tissue Banking, 2(Chapter 2.3), 69-116, 1998
• Wagner JL, Flowers MED, Longton G, Storb R, Schubert M, Sullivan KM., The development of chronic graft-versus-host disease: An analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation, Bone Marrow Transplantation, 22, 139-146, 1998
• Wagner JL, Hayes-Lattin B, Works JD, Storb R, Molecular analysis and polymorphism of the DLA-DQB genes, Tissue Antigens, 52, 242-250, 1998
• Sullivan KM, Kansu E, Storer B, Jocom J, Emerson G, Reagan T, Emerson V, Siadak MF, Davis C, Appelbaum FR, Buckner CD, Hansen JA, Shulman HM, Storb R, McDonald GB, Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation, Biology of Blood and Marrow Transplantation, 4, 20-26, 1998
• Stucki A, Leisenring W, Sandmaier B, Sanders J, Anasetti C, Storb R, Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis), Blood, 92, 2742-2749, 1998
• Wagner JL, Works JD, Storb R, DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing (Brief Communication), 52, 397-401, 1998
• Negrin R, Storb R, Forman S, Bone marrow transplantation in malignant disease, Hematology 1998, The American Society of Hematology Education Program Book, 342-370, 1998
• Martin PJ, Schoch G, Gooley T, Anasetti C, Deeg HJ, Nash R, Sanders J, Storb R, Appelbaum F, Methods for assessment of graft-versus-host-disease (Letter), Blood, 92, 3479-3480, 1998
• Storek J, Gooley T, Siadak M, Bensinger W I, Maloney D G, Chauncey T R, Flowers M, Sullivan K M, Witherspoon R P, Rowley S D, Hansen J A, Storb R, Appelbaum F R, Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease., Blood, 90(12), 4705-9, 15 Dec 1997
• Glimm H, Kiem H P, Darovsky B, Storb R, Wolf J, Diehl V, Mertelsmann R, Von Kalle C, Efficient gene transfer in primitive CD34+/CD38lo human bone marrow cells reselected after long-term exposure to GALV-pseudotyped retroviral vector., Human Gene Therapy, 8(17), 2079-86, 20 Nov 1997
• Schuening F, Longo W L, Atkinson M E, Zaboikin M, Kiem H P, Sanders J, Scott C R, Storb R, Miller A D, Reynolds T, Bensinger W, Rowley S, Gooley T, Darovsky B, Appelbaum F, Retrovirus-mediated transfer of the cDNA for human glucocerebrosidase into peripheral blood repopulating cells of patients with Gaucher's disease., Human Gene Therapy, 8(17), 2143-60, 20 Nov 1997
• Storek J, Mendelman P M, Witherspoon R P, McGregor B A, Storb R, IgG response to pneumococcal polysaccharide-protein conjugate appears similar to IgG response to polysaccharide in bone marrow transplant recipients and healthy adults., Clinical Infectious Diseases, 25(5), 1253-5, November 1997
• Schuening F G, von Kalle C, Kiem H P, Appelbaum F R, Deeg H J, Pepe M, Gooley T, Graham T C, Hackman R C, Storb R, Effect of recombinant canine stem cell factor, a c-kit ligand, on hematopoietic recovery after DLA-identical littermate marrow transplants in dogs., Experimental Hematology, 25(12), 1240-5, November 1997
• Storb R, Aplastic anemia., Journal of Intravenous Nursing, 20(6), 317-22, November 1997
• Storb R, Leisenring W, Anasetti C, Appelbaum F R, Deeg H J, Doney K, Martin P, Sullivan K M, Witherspoon R, Pettinger M, Bensinger W, Buckner C D, Clift R, Flowers M E, Hansen J A, Pepe M, Chauncey T, Sanders J, Thomas E D, Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?, Biology of Blood and Marrow Transplantation, 3(4), 194-201, October 1997
• Anderson J E, Sale G, Appelbaum F R, Chauncey T R, Storb R, Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis., British Journal of Haematology, 98(4), 1010-6, September 1997
• Sierra J, Radich J, Hansen J A, Martin P J, Petersdorf E W, Bjerke J, Bryant E, Nash R A, Sanders J E, Storb R, Sullivan K M, Appelbaum F R, Anasetti C, Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia., Blood, 90(4), 1410-4, 15 Aug 1997
• Kiem H P, Storb R, McDonald G B, Hepatitis-associated aplastic anemia [letter; comment], New England Journal of Medicine, 337(6), 424-5, 7 Aug 1997
• Kiem H P, Myerson D, Storb R, McDonald G B, Spurgeon C L, Leisenring W, Prevalence of hepatitis G virus in patients with aplastic anemia [letter], Blood, 90(3), 1335-6, 1 Aug 1997
• Yu C, Seidel K, Fitzsimmons W E, Sale G, Storb R, Glucocorticoids fail to enhance the effect of FK506 and methotrexate in prevention of graft-versus-host disease after DLA-nonidentical, unrelated marrow transplantation., Bone Marrow Transplantation, 20(2), 137-41, July 1997
• Sierra J, Storer B, Hansen J A, Bjerke J W, Martin P J, Petersdorf E W, Appelbaum F R, Bryant E, Chauncey T R, Sale G, Sanders J E, Storb R, Sullivan K M, Anasetti C, Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose., Blood, 89(11), 4226-35, 1 Jun 1997
• Storek J, Witherspoon R P, Maloney D G, Chauncey T R, Storb R, Improved reconstitution of CD4 T cells and B cells but worsened reconstitution of serum IgG levels after allogeneic transplantation of blood stem cells instead of marrow [letter; comment], Blood, 89(10), 3891-3, 15 May 1997
• Storb R, Leisenring W, Anasetti C, Appelbaum F R, Buckner C D, Bensinger W I, Chauncey T, Clift R A, Deeg H J, Doney K C, Flowers M E, Hansen J A, Martin P J, Sanders J E, Sullivan K M, Witherspoon R P, Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin [letter], Blood, 89(10), 3890-1, 15 May 1997
• Deeg H J, Lin D, Leisenring W, Boeckh M, Anasetti C, Appelbaum F R, Chauncey T R, Doney K, Flowers M, Martin P, Nash R, Schoch G, Sullivan K M, Witherspoon R P, Storb R, Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial., Blood, 89(10), 3880-7, 15 May 1997
• Burnett R C, DeRose S A, Wagner J L, Storb R, Molecular analysis of six dog leukocyte antigen class I sequences including three complete genes, two truncated genes and one full-length processed gene., Tissue Antigens, 49(5), 484-95, May 1997
• McSweeney P A, Nash R A, Storb R, Furst D E, Gauthier J, Sullivan K M, Autologous stem cell transplantation for autoimmune diseases: issues in protocol development., Journal of rheumatology. Supplement, 48, 79-84, May 1997
• Nash R A, McSweeney P A, Storb R, Nelson J L, Gauthier J, Furst D E, Sullivan K M, Development of a protocol for allogeneic marrow transplantation for severe systemic sclerosis: paradigm for autoimmune disease., Journal of rheumatology. Supplement, 48, 72-8, May 1997
• Storb R, Hematopoietic stem cell transplantation in nonmalignant diseases., Journal of rheumatology. Supplement, 48, 30-5, May 1997
• Nelson J L, Torrez R, Louie F M, Choe O S, Storb R, Sullivan K M, Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation., Journal of rheumatology. Supplement, 48, 23-9, May 1997
• Slattery J T, Clift R A, Buckner C D, Radich J, Storer B, Bensinger W I, Soll E, Anasetti C, Bowden R, Bryant E, Chauncey T, Deeg H J, Doney K C, Flowers M, Gooley T, Hansen J A, Martin P J, McDonald G B, Nash R, Petersdorf E W, Sanders J E, Schoch G, Stewart P, Storb R, Appelba, Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation., Blood, 89(8), 3055-60, 15 Apr 1997
• Storb R, Yu C, Wagner J L, Deeg H J, Nash R A, Kiem H P, Leisenring W, Shulman H, Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation., Blood, 89(8), 3048-54, 15 Apr 1997
• Anderson J E, Gooley T A, Schoch G, Anasetti C, Bensinger W I, Clift R A, Hansen J A, Sanders J E, Storb R, Appelbaum F R, Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy., Blood, 89(7), 2578-85, 1 Apr 1997
• Deeg H J, Seidel K, Hong D S, Yu C, Huss R, Schuening F G, Ewel C H, Storb R, In vivo radioprotective effect of AcSDKP on canine myelopoiesis., Annals of Hematology, 74(3), 117-22, March 1997
• Storek J, Gooley T, Witherspoon R P, Sullivan K M, Storb R, Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts., American Journal of Hematology, 54(2), 131-8, February 1997
• Demirer T, Buckner C D, Storer B, Lilleby K, Rowley S, Clift R, Appelbaum F R, Storb R, Bensinger W I, Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor., Journal of Clinical Oncology, 15(2), 684-90, February 1997
• Doney K, Leisenring W, Storb R, Appelbaum F R, Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team [see comments], Annals of Internal Medicine, 126(2), 107-15, 15 Jan 1997
• Storek J, Witherspoon R P, Storb R, Reconstitution of membrane IgD- (mIgD-) B cells after marrow transplantation lags behind the reconstitution of mIgD+ B cells [letter; comment], Blood, 89(1), 350-1, 1 Jan 1997
• Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF Jr, Boice JD Jr, Schoch HG, Sale GE, Storb R, Travis WD, Kolb H-J, Gale RP, Passweg JR, Solid cancers after bone marrow transplantation, New England Journal of Medicine, 336, 897-904, 1997
• Thurston GM, Hayden DL, Burrows P, Clark JI, Taret VG, Kandel J, Courogen M, Peetermans JA, Bowen MS, Miller D, Sullivan KM, Storb R, Stern H, Benedek GB, Quasielastic light scattering study of the living human lens as a function of age, Curr. Eye Res., 16, 197-207, 1997
• Theobald M, Storb R., Transplantation von knochenmark und peripheren stammzellen, Immunologie, Grundlagen-Klinik-Praxis, 4th Edition, Chapter 34, 661-674, 1997
• Storb R, Leisenring W, Anasetti C, Appelbaum FR, Buckner CD, Bensinger WI, Chauncey T, Clift RA, Deeg HJ, Doney KC, Flowers MED, Hansen JA, Martin PJ, Sanders JE, Sullivan KM, Witherspoon RP, Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin (Letter to the Editor), Blood, 89, 3890-3891, 1997
• Sandmaier B M, Storb R, Liu Y, Santos E B, Bryant E, Schuening F G, Deeg H J, Seidel K, Graham T, An anti-CD44 antibody does not enhance engraftment of DLA-identical marrow after low-dose total body irradiation., Transplant Immunology, 4(4), 271-4, December 1996
• Bensinger W I, Buckner C D, Shannon-Dorcy K, Rowley S, Appelbaum F R, Benyunes M, Clift R, Martin P, Demirer T, Storb R, Lee M, Schiller G, Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy., Blood, 88(11), 4132-8, 1 Dec 1996
• Nash R A, Pineiro L A, Storb R, Deeg H J, Fitzsimmons W E, Furlong T, Hansen J A, Gooley T, Maher R M, Martin P, McSweeney P A, Sullivan K M, Anasetti C, Fay J W, FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors., Blood, 88(9), 3634-41, 1 Nov 1996
• Wagner J L, Burnett R C, Storb R, Molecular analysis of the DLA DR region., Tissue Antigens, 48(5), 549-53, November 1996
• Wagner J L, Storb R, Preclinical large animal models for hematopoietic stem cell transplantation., Current Opinion In Hematology, 3(6), 410-5, November 1996
• Nash R A, Storb R, Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL., Current Opinion In Immunology, 8(5), 674-80, October 1996
• Huss R, Deeg H J, Gooley T, Bryant E, Leisenring W, Clift R, Buckner C D, Martin P, Storb R, Appelbaum F R, Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia., Bone Marrow Transplantation, 18(4), 767-76, October 1996
• Bensinger W I, Clift R, Martin P, Appelbaum F R, Demirer T, Gooley T, Lilleby K, Rowley S, Sanders J, Storb R, Buckner C D, Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation., Blood, 88(7), 2794-800, 1 Oct 1996
• Bensinger W I, Buckner C D, Anasetti C, Clift R, Storb R, Barnett T, Chauncey T, Shulman H, Appelbaum F R, Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome., Blood, 88(7), 2787-93, 1 Oct 1996
• Wagner J L, Burnett R C, DeRose S A, Francisco L V, Storb R, Ostrander E A, Histocompatibility testing of dog families with highly polymorphic microsatellite markers., Transplantation, 62(6), 876-7, 27 Sep 1996
• McSweeney P A, Rouleau K A, Storb R, Bolles L, Wallace P M, Beauchamp M, Krizanac-Bengez L, Moore P, Sale G, Sandmaier B, de Revel T, Appelbaum F R, Nash R A, Canine CD34: cloning of the cDNA and evaluation of an antiserum to recombinant protein., Blood, 88(6), 1992-2003, 15 Sep 1996
• Wagner J L, Burnett R C, DeRose S A, Storb R, Molecular analysis and polymorphism of the DLA-DQA gene., Tissue Antigens, 48(3), 199-204, September 1996
• Bensinger W I, Demirer T, Buckner C D, Appelbaum F R, Storb R, Lilleby K, Weiden P, Bluming A Z, Fefer A, Syngeneic marrow transplantation in patients with multiple myeloma., Bone Marrow Transplantation, 18(3), 527-31, September 1996
• Schuening F G, Graham T C, Hackman R, Deeg H J, Storb R, DLA-nonidentical unrelated marrow grafts after high-dose total body irradiation: granulocyte colony-stimulating factor treatment after transplant does not enhance engraftment [letter], Blood, 88(5), 1900-2, 1 Sep 1996
• Kiem H P, Leisenring W, Raff R, Deeg H J, Schuening F G, Appelbaum F R, Storb R, Failure of recombinant stem cell factor to enhance engraftment of L-leucyl-L-leucine methyl ester treated canine marrow after irradiation [letter], Blood, 88(5), 1896-7, 1 Sep 1996
• Walters M C, Patience M, Leisenring W, Eckman J R, Scott J P, Mentzer W C, Davies S C, Ohene-Frempong K, Bernaudin F, Matthews D C, Storb R, Sullivan K M, Bone marrow transplantation for sickle cell disease [see comments], New England Journal of Medicine, 335(6), 369-76, 8 Aug 1996
• Martin P J, Nelson B J, Appelbaum F R, Anasetti C, Deeg H J, Hansen J A, McDonald G B, Nash R A, Sullivan K M, Witherspoon R P, Scannon P J, Friedmann N, Storb R, Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation., Blood, 88(3), 824-30, 1 Aug 1996
• Brunvand M W, Bensinger W I, Soll E, Weaver C H, Rowley S D, Appelbaum F R, Lilleby K, Clift R A, Gooley T A, Press O W, Fefer A, Storb R, Sanders J E, Martin P L, Chauncey T, Maziarz R T, Zuckerman N, Montgomery P, Dorn R, Weiden P L, Demirer T, Holmberg L A, Schiffman K, McSw, High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells., Bone Marrow Transplantation, 18(1), 131-41, July 1996
• Demirer T, Petersen F B, Bensinger W I, Appelbaum F R, Fefer A, Rowley S, Sanders J, Chauncey T, Storb R, Lilleby K, Buckner C D, Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia., Bone Marrow Transplantation, 18(1), 29-34, July 1996
• Deeg H J, Pierpaoli W, Arrighi S, Seidel K, Graham T, Huss R, Yu C, Myerson D, Schuening F, Storb R, Facilitation of DLA-incompatible marrow grafts by donor-specific serum transferrin?, Transplant Immunology, 4(2), 113-6, June 1996
• Schiffman K S, Bensinger W I, Appelbaum F R, Rowley S, Lilleby K, Clift R A, Weaver C H, Demirer T, Sanders J E, Petersdorf S, Gooley T, Weiden P, Zuckerman N, Montgomery P, Maziarz R, Klarnet J P, Rivkin S, Trueblood K, Storb R, Holmberg L, Buckner C D, Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease., Bone Marrow Transplantation, 17(6), 943-50, June 1996
• Demirer T, Buckner C D, Gooley T, Appelbaum F R, Rowley S, Chauncey T, Lilleby K, Storb R, Bensinger W I, Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma., Bone Marrow Transplantation, 17(6), 937-41, June 1996
• Storek J, Witherspoon R P, Webb D, Storb R, Lack of B cells precursors in marrow transplant recipients with chronic graft-versus-host disease., American Journal of Hematology, 52(2), 82-9, June 1996
• Deeg H J, Seidel K, Yu C, Nash R, Huss R, Schuening F, Storb R, Delay of radiation-induced decline and recovery of hematopoiesis following treatment with anti-HLA-DR antibody., Biology of Blood and Marrow Transplantation, 2(2), 105-11, May 1996
• Walters M C, Patience M, Leisenring W, Eckman J R, Buchanan G R, Rogers Z R, Olivieri N E, Vichinsky E, Davies S C, Mentzer W C, Powars D, Scott J P, Bernaudin F, Ohene-Frempong K, Darbyshire P J, Wayne A, Roberts I A, Dinndorf P, Brandalise S, Sanders J E, Matthews D C, Appe, Barriers to bone marrow transplantation for sickle cell anemia., Biology of Blood and Marrow Transplantation, 2(2), 100-4, May 1996
• Kiem H P, McDonald G B, Myerson D, Spurgeon C L, Deeg H J, Sanders J E, Doney K, Appelbaum F R, Sullivan K M, Witherspoon R P, Storb R, Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors., Biology of Blood and Marrow Transplantation, 2(2), 93-9, May 1996
• Clift R A, Storb R, Marrow transplantation for CML: the Seattle experience., Bone Marrow Transplantation, 17 Suppl 3, S1-3, May 1996
• Demirer T, Buckner C D, Appelbaum F R, Clift R, Storb R, Myerson D, Lilleby K, Rowley S, Bensinger W I, High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer., Bone Marrow Transplantation, 17(5), 769-74, May 1996
• Doney K, Storb R, Lilleby K, Appelbaum F R, Recombinant interleukin-1 followed by immunosuppressive therapy for aplastic anemia [letter], American Journal of Hematology, 52(1), 61-2, May 1996
• Bensinger W I, Rowley S D, Demirer T, Lilleby K, Schiffman K, Clift R A, Appelbaum F R, Fefer A, Barnett T, Storb R, Chauncey T, Maziarz R T, Klarnet J, McSweeney P, Holmberg L, Maloney D G, Weaver C H, Buckner C D, High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma., Journal of Clinical Oncology, 14(5), 1447-56, May 1996
• Heimpel H, Allan N C, Baccarani M, Guilhot F, Hehlmann R, Horowitz M, Kluin-Nelemans J, Schaefer U, Storb R, Thaler J, Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia., Bone Marrow Transplantation, 17 Suppl 3, S39, May 1996
• Sandmaier B M, Storb R, Santos E B, Krizanac-Bengez L, Lian T, McSweeney P A, Yu C, Schuening F G, Deeg H J, Graham T, Allogenic transplant of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors., Blood, 87(8), 3508-13, 15 Apr 1996
• Yu C, Storb R, Deeg H J, Graham T C, Scheuning F G, Huss R, Seidel K, Fitzsimmons W E, Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation., Bone Marrow Transplantation, 17(4), 649-53, April 1996
• Demirer T, Buckner C D, Appelbaum F R, Bensinger W I, Sanders J, Lambert K, Clift R, Fefer A, Storb R, Slattery J T, Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan ba, Bone Marrow Transplantation, 17(4), 491-5, April 1996
• Sanders J E, Hawley J, Levy W, Gooley T, Buckner C D, Deeg H J, Doney K, Storb R, Sullivan K, Witherspoon R, Appelbaum F R, Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation., Blood, 87(7), 3045-52, 1 Apr 1996
• Huss R, Hong D S, Beckham C, Storb R, Broudy V C, Deeg H J, Neutralization of stem cell factor in vitro and in vivo: dose-dependent inhibition of stromal cells and induction of granulocyte/monocyte differentiation., Annals of Hematology, 72(4), 253-9, April 1996
• Anderson J E, Anasetti C, Appelbaum F R, Schoch G, Gooley T A, Hansen J A, Buckner C D, Sanders J E, Sullivan K M, Storb R, Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia., British Journal of Haematology, 93(1), 59-67, April 1996
• Bensinger W I, Buckner C D, Demirer T, Storb R, Appelbaum F A, Transplantation of allogeneic peripheral blood stem cells., Bone Marrow Transplantation, 17 Suppl 2, S56-7, March 1996
• Bensinger W I, Buckner C D, Rowley S, Demirer T, Storb R, Appelbaum F A, Transplantation of allogeneic CD34+ peripheral blood stem cells (PBSC) in patients with advanced hematologic malignancy., Bone Marrow Transplantation, 17 Suppl 2, S38-9, March 1996
• Bensinger W I, Buckner C D, Rowley S, Storb R, Appelbaum F R, Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells., Bone Marrow Transplantation, 17 Suppl 2, S19-21, March 1996
• Demirer T, Buckner C D, Appelbaum F R, Lambert K, Bensinger W I, Clift R, Storb R, Slattery J T, Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based o, Bone Marrow Transplantation, 17(3), 341-6, March 1996
• Langston A A, Sanders J E, Deeg H J, Crawford S W, Anasetti C, Sullivan K M, Flowers M E, Storb R, Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita., British Journal of Haematology, 92(3), 758-65, March 1996
• Sullivan K M, Storek J, Kopecky K J, Jocom J, Longton G, Flowers M, Siadak M, Nims J, Witherspoon R P, Anasetti C, Appelbaum F R, Bowden R A, Buckner C D, Crawford S W, Deeg H J, Hansen J A, McDonald G B, Sanders J E, Storb R, A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on s, Biology of Blood and Marrow Transplantation, 2(1), 44-53, February 1996
• Bean M A, Graham T, Appelbaum F R, Deeg H J, Schuening F, Sale G E, Leisenring W, Pepe M, Storb R, Gamma radiation of blood products prevents rejection of subsequent DLA-identical marrow grafts. Tolerance versus abrogation of sensitization to non-DLA antigens., Transplantation, 61(2), 334-5, 27 Jan 1996
• Wagner J L, Deeg H J, Seidel K, Anasetti C, Doney K, Sanders J, Sullivan K M, Storb R, Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience., Transplantation, 61(1), 54-61, 15 Jan 1996
• Kiem H P, Darovsky B, Von Kalle C, Goehle S, Graham T, Miller A D, Storb R, Schuening F G, Long-term persistence of canine hematopoietic cells genetically marked by retrovirus vectors., Human Gene Therapy, 7(1), 89-96, January 1996
• Bensinger W I, Clift R A, Anasetti C, Appelbaum F A, Demirer T, Rowley S, Sandmaier B M, Torok-Storb B, Storb R, Buckner C D, Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor., Stem Cells, 14(1), 90-105, January 1996
• Anderson JE, Appelbaum FR, Schoch G, Gooley T, Anasetti C, Bensinger WI, Bryant E, Buckner CD, Chauncey T, Clift RA, Deeg HJ, Doney K, Flowers M, Hansen JA, Martin PJ, Matthews DC, Nash RA, Sanders JE, Shulman H, Sullivan KM, Witherspoon RP, Storb R., Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: A phase II study of busulfan, cyclophosphamide and total-body irradiation and analysis of prognostic fa, Journal of Clinical Oncology, 14, 220-226, 1996
• Nash RA, Storb R., Graft-versus-host disease after bone marrow transplantation, Principles of Drug Development in Transplantation and Autoimmunity, 47-58, 1996
• Nash RA, Storb R., Tacrolimus-based immunosuppression for the prevention of acute GVHD after marrow transplantation, Principles of Drug Development in Transplantation and Autoimmunity, 10.7, 205-210, 1996
• Flowers MED, Zanis J, Pasquini R, Deeg HJ, Ribeiro R, Longton G, Medeiros CR, Doney K, Sanders J, Bryant E, Hansen J, Sullivan KM, Appelbaum F, Thomas ED, Storb R., Marrow transplantation for Fanconi anaemia: Conditioning with reduced doses of cyclophosphamide without radiation, British Journal of Haematology, 92, 699-706, 1996
• Deeg H J, Socie G, Schoch G, Henry-Amar M, Witherspoon R P, Devergie A, Sullivan K M, Gluckman E, Storb R, Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients., Blood, 87(1), 386-92, 1 Jan 1996
• Anderson J E, Appelbaum F R, Schoch G, Gooley T, Anasetti C, Bensinger W I, Bryant E, Buckner C D, Chauncey T R, Clift R A, Doney K, Flowers M, Hansen J A, Martin P J, Matthews D C, Sanders J E, Shulman H, Sullivan K M, Witherspoon R P, Storb R, Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors., Blood, 87(1), 51-8, 1 Jan 1996
• McSweeney P, Storb R., Bone marrow transplantation for hematologic malignancies and cancer, Immunology and Allergy Clinics of North America. Organ and Bone Marrow Transplantation, 393-427, 1996
• Deeg HJ, Socie G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A, Sullivan KM, Gluckman E, Storb R., Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients, Blood, 87, 386-392, 1996
• Wagner JL, Burnett RC, Storb R., Molecular analysis of the DLA DR region, Tissue Antigens, 48, 549-553, 1996
• Storb R, Deeg H J, Raff R, Schuening F, Yu C, Sandmaier B M, Graham T, Prevention of graft-versus-host disease. Studies in a canine model., Annals of The New York Academy of Sciences, 770, 149-64, 29 Dec 1995
• Soll E, Massumoto C, Clift R A, Buckner C D, Appelbaum F R, Storb R, Sale G, Hackman R, Martin P, Relevance of marrow fibrosis in bone marrow transplantation: a retrospective analysis of engraftment., Blood, 86(12), 4667-73, 15 Dec 1995
• Yu C, Storb R, Mathey B, Deeg H J, Schuening F G, Graham T C, Seidel K, Burnett R, Wagner J L, Shulman H, et al, DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment., Blood, 86(11), 4376-81, 1 Dec 1995
• Bensinger W I, Appelbaum F A, Demirer T, Torok-Storb B, Storb R, Buckner C D, Transplantation of allogeneic peripheral blood stem cells., Stem Cells, 13 Suppl 3, 63-70, December 1995
• Wagner L A, Kiem H P, McSweeney P, Schuening F G, Storb R, Ostrander E A, Development of a clonality assay for canine hematopoietic stem cells [letter], Blood, 86(8), 3265-7, 15 Oct 1995
• Balduzzi A, Gooley T, Anasetti C, Sanders J E, Martin P J, Petersdorf E W, Appelbaum F R, Buckner C D, Matthews D, Storb R, et al, Unrelated donor marrow transplantation in children., Blood, 86(8), 3247-56, 15 Oct 1995
• Storb R, Prevention of graft-versus-host disease after bone marrow transplantation., Transplantation Proceedings, 27(5), 2653-6, October 1995
• Storb R, Bone marrow transplantation., Transplantation Proceedings, 27(5), 2649-52, October 1995
• Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C, et al, Factors that influence collection and engraftment of autologous peripheral-blood stem cells., Journal of Clinical Oncology, 13(10), 2547-55, October 1995
• Nash R A, Storb R, Transplantation of hematopoietic stem cells., Proceedings of The Association of American Physicians, 107(3), 288-95, October 1995
• Storek J, Witherspoon R P, Storb R, T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life., Bone Marrow Transplantation, 16(3), 413-25, September 1995
• Burnett R C, Francisco L V, DeRose S A, Storb R, Ostrander E A, Identification and characterization of a highly polymorphic microsatellite marker within the canine MHC class I region., Mammalian Genome, 6(9), 684-5, September 1995
• Kalhs P, Schwarzinger I, Anderson G, Mori M, Clift R A, Storb R, Buckner C D, Appelbaum F R, Hansen J A, Sullivan K M, A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leu, Blood, 86(5), 2028-32, 1 Sep 1995
• Nash R A, Burstein S A, Storb R, Yang W, Abrams K, Appelbaum F R, Boone T, Deeg H J, Durack L D, Schuening F G, Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating platelets., Blood, 86(5), 1765-75, 1 Sep 1995
• Yu C, Storb R, Braude I, Deeg H J, Schuening F G, Huss R, Graham T C, Corticotropin releasing factor with or without methotrexate for prevention of graft-versus-host disease in DLA-nonidentical unrelated canine marrow grafts., Transplantation, 60(4), 384-6, 27 Aug 1995
• Doney K C, Storb R, Beach K, Anasetti C, Deeg H J, Hansen J A, Martin P J, Nash R A, Schubert M M, Sullivan K M, et al, A toxicity study of trimetrexate used in combination with cyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplants., Transplantation, 60(1), 55-8, 15 Jul 1995
• Demirer T, Petersen F B, Appelbaum F R, Barnett T A, Sanders J, Deeg H J, Storb R, Doney K, Bensinger W I, Shannon-Dorcy K, et al, Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trial., International Journal of Radiation Oncology, Biology, Physics, 32(4), 1103-9, 15 Jul 1995
• Demirer T, Rowley S, Buckner C D, Appelbaum F R, Lilleby K, Storb R, Schiffman K, Bensinger W I, Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer., Journal of Clinical Oncology, 13(7), 1714-9, July 1995
• Hong D S, Graham T, Ewel C, Storb R, Deeg H J, Inhibition of hematopoiesis in long-term marrow cultures established on adherent layers from AcSDKP-treated dogs., Experimental Hematology, 23(7), 639-44, July 1995
• Nash R A, Etzioni R, Storb R, Furlong T, Gooley T, Anasetti C, Appelbaum F R, Doney K, Martin P, Slattery J, et al, Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a singl, Blood, 85(12), 3746-53, 15 Jun 1995
• Demirer T, Buckner C D, Appelbaum F R, Petersen F B, Rowley S, Weaver C H, Lilleby K, Sanders J, Chauncey T, Storb R, et al, Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leuke, Bone Marrow Transplantation, 15(6), 915-22, June 1995
• Demirer T, Gooley T, Buckner C D, Petersen F B, Lilleby K, Rowley S, Sanders J, Storb R, Appelbaum F R, Bensinger W I, Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation., Bone Marrow Transplantation, 15(6), 907-13, June 1995
• Ehninger G, Schuler U, Renner U, Ehrsam M, Zeller K P, Blanz J, Storb R, Deeg H J, Use of a water-soluble busulfan formulation--pharmacokinetic studies in a canine model., Blood, 85(11), 3247-9, 1 Jun 1995
• Storb R, Raff R F, Deeg H J, Graham T C, Schuening F G, Shulman H, Bryant E, DLA-identical marrow grafts after low-dose total-body irradiation. Addition of viable donor peripheral blood mononuclear cells does not enhance engraftment., Transplantation, 59(10), 1481-2, 27 May 1995
• Storek J, Witherspoon R P, Luthy D, Storb R, Low IgG production by mononuclear cells from marrow transplant survivors and from normal neonates is due to a defect of B cells., Bone Marrow Transplantation, 15(5), 679-84, May 1995
• Nash R A, Seidel K, Storb R, Slichter S, Schuening F G, Appelbaum F R, Becker A B, Bolles L, Deeg H J, Graham T, et al, Effects of rhIL-11 on normal dogs and after sublethal radiation., Experimental Hematology, 23(5), 389-96, May 1995
• Wagner J L, DeRose S A, Burnett R C, Storb R, Nucleotide sequence and polymorphism analysis of canine DRA cDNA clones., Tissue Antigens, 45(4), 284-7, April 1995
• Bensinger W I, Weaver C H, Appelbaum F R, Rowley S, Demirer T, Sanders J, Storb R, Buckner C D, Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor [see comments], Blood, 85(6), 1655-8, 15 Mar 1995
• Anderson J E, Appelbaum F R, Storb R, An update on allogeneic marrow transplantation for myelodysplastic syndrome., Leukemia and Lymphoma, 17(1-2), 95-9, March 1995
• Kiem H P, von Kalle C, Schuening F, Storb R, Gene therapy and bone marrow transplantation [see comments], Current Opinion In Oncology, 7(2), 107-14, March 1995
• Barquinero J, Kiem H P, von Kalle C, Darovsky B, Goehle S, Graham T, Seidel K, Storb R, Schuening F G, Myelosuppressive conditioning improves autologous engraftment of genetically marked hematopoietic repopulating cells in dogs., Blood, 85(5), 1195-201, 1 Mar 1995
• Langenmayer I, Weaver C, Buckner C D, Lilleby K, Appelbaum F R, Longin K, Rowley S, Storb R, Singer J, Bensinger W I, Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both., Bone Marrow Transplantation, 15(2), 241-6, February 1995
• Hong D S, Huss R, Beckham C, Hoy C A, Storb R, Deeg H J, Major histocompatibility complex class II-mediated inhibition of hemopoiesis in vitro and in vivo is abrogated by c-kit ligand., Transplantation Proceedings, 27(1), 642-3, February 1995
• Fay J W, Nash R A, Wingard J R, Przepiorka D, Collins R H, Anasetti C, Devine S M, Pineiro L A, Storb R F, Aro R M, et al, FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation., Transplantation Proceedings, 27(1), 1374, February 1995
• Jakic-Razumovic J, Sale G E, Beauchamp M D, Storb R, Sandmaier B M, CD8+ activated T lymphocytes produce an in vitro skin graft-versus-host reaction in an organotypic skin culture model., Transplantation, 59(1), 69-78, 15 Jan 1995
• Kalhs P, White J S, Gervassi A, Storb R, Bean M A, In vitro recall of proliferative and cytolytic responses to minor histocompatibility antigens by dendritic cell enriched canine peripheral blood mononuclear cells., Transplantation, 59(1), 112-8, 15 Jan 1995
• Barquinero J, Witherspoon R, Sanders J, Horowitz MM, Montuoro A, Patton DF, Bacigalupo A, Abercasis MM, Miale T, Rozman C, Bryant E, Storb R., Allogeneic marrow grafts from donors with congenital chromosomal abnormalities in marrow cells, British Journal of Haematology, 90, 595-601, 1995
• Deeg HJ, Doney K, Anasetti C, Storb R., Transplant and nontransplant therapy for patients with severe aplastic anemia: an update of the Seattle experience, Ontogeny of Hematopoiesis Aplastic Anemia: An Update of the Seattle Experience, 307-312, 1995
• Demirer T, Weaver CH, Buckner CD, Petersen FB, Bensinger WI, Sanders J, Clift RA, Lilleby K, Anasetti C, Martin P, Storb R, Chauncey T, Doney K, Sullivan K, Appelbaum FR., High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy, Journal of Clinical Oncology, 13, 596-602, 1995
• Benyunes MC, Sullivan KM, Deeg HJ, Mori M, Meyer W, Fisher L, Bensinger R, Jack MK, Hicks J, Witherspoon R, Buckner CD, Hansen JA, Appelbaum FR, Storb R., Cataracts after bone marrow transplantation: Long-term follow-up of adults treated with fractionated total body irradiation, International Journal of Radiat, 32, 661-670, 1995
• Lynch M H, Petersen F B, Appelbaum F R, Bensinger W I, Clift R A, Storb R, Sanders J E, Hansen J A, Buckner C D, Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies., Bone Marrow Transplantation, 15(1), 59-64, January 1995
• Huss R, Hong D S, Beckham C, Kimball L, Myerson D H, Storb R, Deeg H J, Ultrastructural localization of stem cell factor in canine marrow-derived stromal cells., Experimental Hematology, 23(1), 33-40, January 1995
• Storb R, Anasetti C, Appelbaum FR, Deeg HJ, Doney K, Martin P, Nash R, Sullivan K, Witherspoon R., Immunosuppressive agents for prevention of graft-versus-host disease, Bone Marrow Transplantation, 15, S98-S103, 1995
• Matthews DC, Appelbaum FR, Eary JF, Fisher DR, Durack LD, Bush SA, Hui E, Martin PJ, Mithcell D, Press OW, Badger CC, Storb R, Nelp WB, Bernstein ID., Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131 I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irra, Blood, 85, 1122-1131, 1995
• Walters MC, Sullivan KM, Bernaudin F, Souillet G, Vannier J-P, Johnson FL, Lenarsky C, Powars D, Bunin N, Ohene-Frempong K, Wall D, Michel G, Plouvier E, Bodigoni P, Lutz P, Sanders JE, Matthews DC, Patience M, Appelbaum FR, Storb R., Rapid Communication: Neurologic complications after allogeneic marrow transplantation for sickle cell anemia, Blood, 85, 879-884, 1995
• Mathey B, Storb R., Allogeneic bone marrow transplantation: General principles and current practice, Principles of Transfusion Medicine, 2nd Edition, 44, 475-491, 1995
• Storb R, Thomas ED., Transplantation of bone marrow, Samter's Immunologic Diseases. 5th Edition, 1471-1493, 1995
• Mathey B, Storb R., Allogeneic bone marrow transplantation: Current problems and possible solutions, Principles of Transfusion Medicine, 2nd Edition, 45, 493-508, 1995
• Kiem H-P, Barquinero J, von Kalle C, Darovsky B, Goehle S, Storb R, Schuening FG., Influence of different conditioning regimens on engraftment of genetically marked hematopoietic stem cells, Autologous Marrow and Blood Transplantation- Proceedings of the Seventh International Symposium, 261-269, 1995
• Mathey B, Yu C, Sandmaier BM, Deeg HJ, Graham T, Schuening FG, Nash RA, Storb R., Failure of interleukin-1 and granulocyte-macrophage colony-stimulating factor to enhance allogeneic marrow engraftment and survival in irradiated dogs (letter), Blood, 86, 833-834, 1995
• Schuening FG, Von Kalle C, Kiem H-P, To RY, Goehle S, Darovsky B, Storb R., Gene transfer into canine and human hematopoietic cells, Biology of Hematopoiesis and Stem Cell Gene Transfer, 17, 247-260, 1995
• Thurston GM, Hayden DL, Burrows P, Clark JI, Taret VG, Kandel J, Courogen M, Peetermans JA, Bowen MS, Miller D, Sullivan KM, Storb R, Stern H, Benedek GB., Quasielastic light scattering from the aging human lens in vivo, Vision Science and its Applications, 57-60, 1995
• Storb R., Preparative regimens for patients with leukemias and severe aplastic anemia- Biological basis, experimental animal studies and clinical trials at the Fred Hutchinson Cancer Research Center, Radiation Research: 1895-1995, Congress Proceedings, 948-952, 1995